Novo Nordisk Shares Drop After Trump Announces Plan to Lower Ozempic Price
Oct 17, 2025
Shares of Novo Nordisk fell about 5% after U.S. President Donald Trump announced that the price of the company's best-selling weight-loss drug, Ozempic, would be lowered.
Trump stated on Thursday that negotiations to reduce the cost of Ozempic would be quick, and that the new, lower price would benefit Americans. He emphasized that the current price of the drug is too high.
Some other pharmaceutical stocks, such as Eli Lilly, also saw declines following Trump's comments about lowering prices on weight-loss medications.
Why did Novo Nordisk's stock price fall?
The stock dropped after President Trump said Ozempic's price would be reduced, which could lower the company's profits from the popular drug.
What is Ozempic?
Ozempic is a weight-loss drug made by Novo Nordisk that is widely used to help people lose weight.
Who will benefit from the lower price?
Trump stated that the lower price will benefit Americans, especially those who need the drug for weight loss.
Are other drug companies affected by this announcement?
Yes, stocks of other companies that make weight-loss drugs, like Eli Lilly, also declined after the announcement.
Sources
Trump says price of Ozempic will be lowered
Reuters
Reuters
U.S. President Donald Trump said on Thursday that the price of Novo Nordisk's best-selling weight-loss drug would be lowered and that negotiations over price changes would be swift.
Novo Nordisk shares fall 5% after Trump vows weight-loss drug price cut
Reuters
Reuters
Novo Nordisk's shares fell around 5% in early trade on Friday after U.S. President Donald Trump said on Thursday that the price of the Danish drugmaker's best-selling weight-loss drug would be lowered.
Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs
WSJ
WSJ
The president said the cost of the weight-loss drug should be much lower for Americans once negotiations with Novo Nordisk had concluded.
Eli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to...
Barrons
Barrons
Trump told reporters late Thursday that the list price of Ozempic, which he called “the fat loss drug,” will be “much lower.”
Novo Nordisk, Eli Lilly shares drop as Trump promises lower weight loss drug pri...
Proactive Investors
Proactive Investors
Shares of Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY), two major pharmaceutical companies that produce weight-loss drugs, dropped sharply following comments from US president Donald Trump about reductions in the prices of these medicines. During a White House event focused on fertility t...
Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
Reuters
Reuters
Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, according to a statement he posted on LinkedIn, as the obesity drugmaker faces growing pressure from the Trump administration on drug pricing.
Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Dr...
Benzinga
Benzinga
President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S (NYSE:NVO) blockbuster drug Ozempic from around $1,300 to $150 isn't just about affordability—it's about shaking the foundations of the GLP-1 gold rush that'...
Is Trump Going to Kill the GLP-1 Cash Cow?
24/7 Wall Street
24/7 Wall Street
GLP-1 drugs propelled Novo Nordisk (NVO) and Eli Lilly (LLY) to record profits, with sales exceeding $20 billion amid skyrocketing demand. Both companies cut prices recently to expand access, but President Trump's vow threatens deeper reductions.
Here's What Trump Said That's Pressuring Novo Nordisk and Eli Lilly Stocks
Investopedia
Investopedia
Novo Nordisk (NVO) and Eli Lilly (LLY) shares slumped in early trading Friday after President Trump promised to lower the prices of popular weight-loss drugs, such as Novo Nordisk's Ozempic and Eli Lilly's Zepbound.
NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs
Zacks Investment Research
Zacks Investment Research
Trump's pledge to slash GLP-1 drug prices sends Novo Nordisk and Eli Lilly shares tumbling, raising questions about the feasibility of such a development.
Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.
Investors Business Daily
Investors Business Daily
Novo Nordisk and Eli Lilly stocks slumped Friday after President Donald Trump said he would cut the price of weight-loss drugs.
Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Prof...
Benzinga
Benzinga
Novo Nordisk A/S (NASDAQ:NVO) is back in the headlines, and not just for its blockbuster weight-loss drug, Ozempic. President Donald Trump recently suggested a dramatic price cut for the drug, sparking some short-term market jitters.
Trump says Ozempic prices will be 'much lower' for Americans
Fox Business
Fox Business
President Donald Trump said there will be lower prices for Ozempic after negotiations with Novo Nordisk as part of his broader initiative to reduce prescription drug costs.
Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP...
CNBC
CNBC
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price. Centers for Medicare and Medicaid Administrator Dr. Mehmet Oz interjected an...
President Trump targets $150 MFN price for GLP-1s
CNBC Television
CNBC Television
Shares of Eli Lilly and Novo Nordisk came under pressure after President Trump said during an event at the White House that the administration is looking bring down prices of popular weight loss GLP-1s to $150 per month.
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
The Motley Fool
The Motley Fool
Novo Nordisk (NVO 2.60%), a Denmark-based drugmaker, was a pioneer in the GLP-1 market. The pharmaceutical giant launched medicines like Ozempic and Wegovy, which became hugely famous and successful brand names.
Insight: Novo Nordisk fights to keep Medicaid paying for weight-loss drugs
Reuters
Reuters
Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as some U.S. states struggle with the treatment's costs, according to state documents, company emails and interviews with lawmakers and advocates.
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Oct 2025...
24/7 Wall Street
24/7 Wall Street
Ozempic has become a phenomenon, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO).
Novo Nordisk in active talks with Trump administration on MFN
CNBC Television
CNBC Television
Novo Nordisk U.S. President Dave Moore confirms the company is in active discussions with the Trump administration over most favored nation pricing for its popular GLP-1 drugs Ozempic and Wegovy, as it wraps up talks for the IRA Medicare drug price negotiations. It comes as the company is ramping up...
Related Posts
Other News
Corporate Moves
View All
SentinelOne Shares Fall After CFO Departure and Weak Revenue Outlook
Dec 5, 2025
S
-14.44%
SentinelOne, a cybersecurity company, reported its third-quarter financial results, showing strong growth and improved margins. Despite this performance, the company gave a revenue forecast for the ne...
Amazon May End US Postal Service Partnership to Expand Own Delivery Network
Dec 4, 2025
AMZN
+0.18%
Amazon is reportedly considering ending its long-running contract with the United States Postal Service (USPS). This change would allow Amazon to rely more on its own growing nationwide delivery netwo...
Meta to Make Deep Cuts to Metaverse Budget as AI Becomes Priority
Dec 4, 2025
META
+1.8%
Meta Platforms CEO Mark Zuckerberg plans to significantly cut spending on the company's metaverse efforts, according to reports from Bloomberg News. The expected budget cuts could be as much as 30% fo...
Product Launches
View All
Amazon Unveils New AI Chips and Tools to Boost Cloud Capabilities
Dec 2, 2025
AMZN
+0.18%
Amazon Web Services (AWS) has introduced new artificial intelligence (AI) chips and software tools aimed at improving the performance and reliability of its cloud computing services.
A key highlight...
Samsung Launches World’s First Triple-Folding Smartphone, the Galaxy Z TriFold
Dec 2, 2025
005930
+1.34%
Samsung Electronics has unveiled its first multi-folding smartphone, the Galaxy Z TriFold. This new device folds inward twice, creating a three-panel design with a large 10-inch inner display.
The la...
Amazon and Google Launch Joint Multicloud Networking Service
Dec 1, 2025
GOOGL
+1.15%
AMZN
+0.18%
Amazon and Google have announced a new multicloud networking service to improve connectivity between their cloud platforms. This jointly developed solution is designed to provide businesses with a fas...
Regulatory Actions
View All
The New York Times Sues Perplexity AI Over Copyright Infringement
Dec 5, 2025
NYT
+1.11%
The New York Times has filed a lawsuit against Perplexity AI, accusing the artificial intelligence startup of copyright infringement. The newspaper says Perplexity copied, distributed, and displayed m...
New York Times Sues Pentagon Over Restrictive Press Rules
Dec 4, 2025
NYT
+1.11%
The New York Times has filed a lawsuit against the U.S. Department of Defense and Defense Secretary Pete Hegseth over new press rules at the Pentagon. The newspaper claims that the new policy restrict...
EU Launches Antitrust Investigation into Meta’s Use of AI in WhatsApp
Dec 4, 2025
META
+1.8%
The European Union has started an antitrust investigation into Meta Platforms, the company that owns WhatsApp, over its use of artificial intelligence (AI) features within the messaging app.
EU regul...
Earnings
View All
Broadcom Shares Rise Ahead of Key Earnings Report as Analysts Boost Targets
Dec 5, 2025
AVGO
+2.42%
Broadcom, a major semiconductor company, is drawing attention as it prepares to release its quarterly earnings next week. Both analysts and investors are optimistic, with the stock rising nearly 3% an...
Victoria's Secret Shares Jump After Strong Q3 Earnings and Higher Sales Outlook
Dec 5, 2025
VSCO
+17.99%
Victoria's Secret & Co. reported its third quarter 2025 earnings, showing stronger results than Wall Street had expected. Net sales for the quarter reached $1.472 billion, which is a 9% increase from...
DocuSign Shares Fall Despite Strong Q3 Fiscal 2026 Earnings Beat
Dec 5, 2025
DOCU
-7.64%
DocuSign announced its third quarter fiscal 2026 financial results, reporting revenue of $818.4 million for the period ending October 31, 2025. This result exceeded Wall Street's estimate of about $80...
Stock Movements
View All
Cloudflare Outage Causes Widespread Website Disruptions, Services Restored
Dec 5, 2025
NET
-1.57%
Cloudflare, an internet infrastructure company, experienced a service outage on Friday that caused several major websites to go down. Affected sites included LinkedIn, Zoom, Canva, Shopify, crypto tra...
D-Wave Quantum Stock Experiences Volatility Amid Valuation Concerns and Industry Advances
Dec 5, 2025
QBTS
-6.02%
D-Wave Quantum (QBTS) stock has recently faced significant fluctuations. Over the past 21 trading days, the stock declined by about 24.2%, drawing attention to concerns over the company's high valuati...
SoFi Announces $1.5 Billion Public Offering, Stock Falls Over 6%
Dec 5, 2025
SOFI
-6.15%
SoFi Technologies, a financial technology company, has launched a public offering to sell $1.5 billion worth of its common stock. The company priced 54,545,454 shares at $27.50 each. All of the shares...
Economy
View All
US Stock Market Holds Steady as Investors Await Key Inflation Data
Dec 5, 2025
The S&P 500 inched up by 0.15% as US stock market indexes remained close to their record highs. This comes as investors await a key inflation report, the Personal Consumption Expenditures (PCE) index....
ADP Report: Private Sector Lost 32,000 Jobs in November, Wages Up 4.4% Over Year
Dec 3, 2025
According to the November ADP National Employment Report, private sector employment in the United States decreased by 32,000 jobs. This data was compiled by ADP Research in collaboration with the Stan...
Nvidia's AI Chip Leadership Spurs Industry Growth and Component Shortages
Dec 2, 2025
NVDA
-0.53%
Nvidia, a leader in artificial intelligence (AI) chips, continues to drive strong growth in the technology sector. The company has seen high demand for its graphics processing units (GPUs), particular...
Analyst Ratings
View All
‘Big Short’ Investor Michael Burry Calls Tesla ‘Ridiculously Overvalued’
Dec 1, 2025
TSLA
+0.1%
Michael Burry, the investor known for predicting the 2008 financial crisis, has criticized Tesla's stock valuation. In a recent blog post, Burry described Elon Musk's electric car company as 'ridiculo...
Carvana Stock Upgraded by Wedbush, Price Target Raised to $400
Nov 24, 2025
CVNA
+0.23%
Carvana, an online used car retailer, saw its stock rise over 7% on Monday after analysts at Wedbush Securities upgraded the stock from 'Neutral' to 'Outperform.'
Wedbush analysts raised their 12-mon...
Dell Stock Falls After Morgan Stanley Downgrade Over Memory Chip Costs
Nov 17, 2025
DELL
-0.06%
Dell Technologies shares dropped by about 7% to $124.44 after Morgan Stanley downgraded the stock from 'overweight' to 'underweight' and lowered its price target to $110. The downgrade reflects concer...
Mergers & Acquisitions
View All
Meta Acquires AI Wearables Startup Limitless
Dec 5, 2025
META
+1.8%
Meta has announced the acquisition of Limitless, a startup that specializes in artificial intelligence-powered wearables. Limitless is known for its pendant-style device that can record and transcribe...
Netflix To Acquire Warner Bros. Discovery’s Film and Streaming Businesses in Massive Deal
Dec 5, 2025
NFLX
-2.89%
WBD
+6.28%
Netflix has agreed to acquire Warner Bros. Discovery’s film studios and streaming division, including HBO Max, in a deal valued at up to $83 billion. The agreement will make Netflix one of the largest...
Hims & Hers Expands Into Canada After Acquiring Digital Health Platform Livewell
Dec 4, 2025
HIMS
-2.05%
Hims & Hers Health, a leading US digital health company, has officially expanded its services into Canada. This move follows its recent acquisition of Livewell, a Canadian digital health platform know...
IPO
View All
Navan Raises $923 Million in IPO Amid US Government Shutdown
Oct 30, 2025
NAVN
-4.57%
Navan, a business travel and expense management company, has completed its initial public offering (IPO) by selling 36,924,406 shares of its Class A common stock at $25 per share. The IPO raised appro...
Beta Technologies Launches IPO, Aiming to Raise Up to $825 Million
Oct 16, 2025
BETA
-4.86%
Beta Technologies, a company that makes electric aircraft, has set the terms for its initial public offering (IPO) in the United States.
The company plans to offer 25 million shares of its Class A co...
Fermi Shares Surge After High-Profile IPO Despite Lack of Revenue
Oct 2, 2025
FRMI
-4.71%
Fermi Inc., a start-up focused on building large data centers for artificial intelligence, saw its stock price soar following its initial public offerings on both the Nasdaq in New York and the London...
